|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net loss | |||||
| Net loss before tax | |||||
| Loss from operations | |||||
| Gross profit | |||||
| Revenue | |||||
| Cost of sales | |||||
| Total operating expenses | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Amortization of acquired intangible assets | |||||
| Total operating expenses | |||||
| Impairment of long-lived and indefinite-lived assets | |||||
| Other operating income | |||||
| Total other income (expense) | |||||
| Investment income, net | |||||
| Interest Expense, Nonoperating | |||||
| Income Tax Expense (Benefit) | |||||
| Increase (decrease) in net loss per share (in usd per share) | |||||
| Weighted average number of shares outstanding, basic (in shares) | |||||
| Weighted average number of shares outstanding, diluted (in shares) | |||||
Loading...